J. Bourhis

Surgery · Radiotherapy and Oncology · 2000–2019

A researcher in the Science corpus: 17 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Surgery — 18 citations into it
• Statistics and Probability — 6 citations into it

Whom J. Bourhis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Julian P. T. Higgins

Who trusts J. Bourhis overall

1. Jean-Pierre Pignon

Papers from J. Bourhis's perspective

Ordered by how strongly the researchers J. Bourhis trusts endorse each paper. Same corpus, a different order for every researcher.

1. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
2. Inhibition of neurogenesis interferes with hippocampus‐dependent memory function
3. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice.
4. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed (Journal of Neuroinflammation)
5. Epidermal stem cells of the skin. (Annual Review of Cell and Developmental Biology)
6. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. (New England Journal of Medicine)
7. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. (New England Journal of Medicine)
8. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. (Journal of Clinical Oncology)
9. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans (Nature Genetics)
10. Calreticulin exposure dictates the immunogenicity of cancer cell death (Nature Medicine)

Their papers

• Treatment of a first patient with FLASH-radiotherapy. (2019) — 610 citations
• The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients (2018) — 637 citations
• Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. (2017) — 605 citations
• CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. (2015) — 597 citations
• Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. (2015) — 712 citations
• Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice (2014) — 1,296 citations
• Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. (2012)
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. (2011) — 611 citations
• Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. (2010) — 766 citations
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. (2009) — 2,996 citations
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (2007) — 3,002 citations
• Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. (2006) — 675 citations
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. (2006) — 1,048 citations
• Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. (2006) — 633 citations
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) (2005) — 1,688 citations
• Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. (2004) — 2,975 citations
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data (2000) — 2,306 citations